Syndax Pharmaceuticals Inc — Director's Dealing 2021

Apr 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Syndax Pharmaceuticals Inc (SNDX)
CIK: 0001395937
Period of Report: 2021-04-22

Reporting Person: Podlesak Dennis (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-22	Common Stock	P	13967.00	$14.1102	Acquired	43300.00	Direct

Footnotes

F1: The purchase prices ranged from $13.98 to $14.29.